The global
patient registry software market is expected to reach USD 1,429.1 million by
2022 from USD 807.4 million in 2017, at a CAGR of 12.1%. Growth in this market is mainly driven by factors such
as government initiatives to build patient registries, rising pressure to
improve the quality of care and reduce healthcare costs, rising adoption of
EHRs, and growing use of patient registry data for post-marketing surveillance.
With the rapidly growing geriatric population and increasing prevalence of
chronic diseases, the necessity of population health management has increased. This draws attention towards registry tools.
The high adoption of information technology across the globe also supports the
growth of this market
Partnerships,
collaborations, contracts, agreements, and acquisitions accounted for the majority
of the growth strategies adopted by players to sustain their growth in the
market.
View more detailed
TOC @
http://www.marketsandmarkets.com/Market-Reports/patient-registry-software-market-144694594.html
The patient registry software market is fragmented with several big and small
players. Players offer several products across different subsegments of this market. Key players in this
market include Phytel, Inc. (US), QUINTILES IMS HOLDINGS, INC. (US), Liaison
Technologies. (US), ImageTrend, Inc. (US),
FIGmd, Inc. (US), McKesson Corporation (US), CECity.com Inc. (a Premier, Inc.
Company) (US), Dacima Software Inc. (US), Global Vision Technologies, Inc.
(US), ifa systems AG, (Germany), INC RESEARCH HOLDINGS, INC. (US), M2S
(A Medstreaming Company) (US), Optum, Inc (A part of UnitedHealth Group
Incorporated) (US), EVADO Pty. Ltd. (Australia), and Velos, Inc. (US).
In 2017, Phytel, Inc. is among the leading players in the
patient registry software market. The company mainly focuses on providing
population health management solutions to government organizations; TPAs;
pharmaceutical, biotechnology, and medical device companies; hospitals; and
research centers. The company has a wide geographical presence across the
Americas, Europe, the Middle East, Africa, and Asia Pacific. In order to maintain its position in the
market, the company adopts various organic as well as inorganic strategies. For
instance, in 2016, Phytel agreed with Cleveland Clinic (US) to establish a
model for a health system transition to value-based care and population health.
Such developments helped the company to enhance its presence in the patient
registry software market.
Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=144694594
QUINTILES IMS HOLDINGS, INC. has maintained its
position in the market by offering high-quality registry solutions. The company
has a wide R&D platform with data spanning 298,000+ clinical investigators,
487 indications, and 18 therapeutic areas. In addition,
a highly skilled workforce in the company with approximately 900+ clinical
educators, 1,100+ medical doctors, and 1,050 PhDs 1,200+ experts in healthcare
informatics gives the company a competitive edge. QUINTILES also focuses on partnerships, acquisitions, and
expansions to maintain its position in the market. In 2016, IMS and Quintiles merged
to create a global leader in healthcare intelligence.
No comments:
Post a Comment